GB2274235A - Carotenoid food supplement - Google Patents

Carotenoid food supplement Download PDF

Info

Publication number
GB2274235A
GB2274235A GB9324188A GB9324188A GB2274235A GB 2274235 A GB2274235 A GB 2274235A GB 9324188 A GB9324188 A GB 9324188A GB 9324188 A GB9324188 A GB 9324188A GB 2274235 A GB2274235 A GB 2274235A
Authority
GB
United Kingdom
Prior art keywords
composition
carotene
carotenoids
lycopene
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9324188A
Other versions
GB2274235B (en
GB9324188D0 (en
Inventor
Arianna Carughi
Arthur Furst
Fred G Hooper
John R Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEO LIFE Co OF AMERICA
Original Assignee
NEO LIFE Co OF AMERICA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEO LIFE Co OF AMERICA filed Critical NEO LIFE Co OF AMERICA
Publication of GB9324188D0 publication Critical patent/GB9324188D0/en
Publication of GB2274235A publication Critical patent/GB2274235A/en
Application granted granted Critical
Publication of GB2274235B publication Critical patent/GB2274235B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01Instant products; Powders; Flakes; Granules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives

Abstract

A diet supplement composition containing powdered, dried fruits and vegetables rich in alpha-carotene, beta-carotene and lycopene encapsulated in a gelatin capsule in an edible oil.

Description

CAROTEDIOID FOOD SUPPLEMENT ECH!TICAL FIELD This invention is in the field of food supplements to provide carotenoids at optimal ingestion levels.
BCKGOUID Aki Carotenoids are the most numerous group of pigments in nature. They play a critical role in electron transport reactions in plants and are indispensable to healthy functioning of human beings and most animals. The full extent of their role in physiology is not known but experimental evidence indicates that carotenoids may be necessary for proper functioning of the immune system and for pro-tecting tissue from ultraviolet damage.
They may reduce chemically induced neoplasia and malignant cell transformation.
Carotenoids are found in fruits and vegetables and an adequate intake of carotenoids, the amount recommended by government agencies and the medical profession, requires ingestion of far more fruits and vegetables than the average diets of persons in the United States and other nations in the Western culture provide. Among better-known carotenoids are alpha-carotene, beta-carotene and lycopene. In addition to being found in fruits and vegetables, beta-carotene is synthesized and the synthetic compound is commercially available. However, there are hundreds of lesser-studied carotenoids that are found in fruits and vegetables, hereinafter referred to collectively as vegetables, and those lesser-known carotenoids are not present in synthetic preparations such as beta-carotene.The lesser-known carotenoids may play an important (albeit, not fully explored) role in human health as indicated by illnesses or malfunctioning of persons in the Western culture whose diets do not contain enough vegetables. Many of these illnesses or malfunctions are less frequent among persons in populations where diets include large amounts of vegetables. The beneficial effects of lesserstudied or unknown carotenoids may be due to their direct effectiveness in trace amounts or to catalytic or synergistic effects that they-exert with the better-known and more thoroughly studied carotenoids such as beta-carotene. Synthetic carotenoids also lack natural distributions of structural differences in their molecules, such as cis- and trans- forms which occur in natural proportions in vegetables. This phenomenon is observed in many ways.For example, when experimental animals are fed either natural or synthetic beta-carotene, liver analyses show at least ten-fold higher levels of beta-carotene in those animals fed the natural form.
DISCLOSURE OF THE INVENTION This invention is a composition useful as a dietary supplement which provides adequate carotenoid ingestion to persons regardless of the inadequacy of their diets with respect to their vegetable intake. The composition of this invention not only provides adequate quantities of known carotenoids to the diet but it additionally provides the natural level of lesser known and even unknown carotenoids so that the ingestion of a full spectrum of carotenoids in naturally balanced proportions is achieved by supplementing the diet with the composition of this invention.
This invention is an encapsulated composition of powdered vegetable material in an edible oil base. The composition comprises vegetable material that provides alphacarotene, beta-carotene and lycopene in proportion to each other of about 20 percent to aluout 40 percent alpha-carotene, about 55 percent to about 80 percent beta-carotene, and about 3 percent to about 20 percent lycopene - the percentayes being the weight relationships of those three carotenoids to each other. By providing those carotenoids in that proportion from vegetable materials, the whole array of carotenoids in approximately the balanced composition relationships found in the diet is provided in the composition of this invention.Vegetables that contain high quantities of alpha- and beta-carotene do not contain high quantities of lycopene but they have their own array of other carotenoids. However, those vegetables providing high concentrations of lycopene have an array of carotenoids that are different from the other carotenoids in those vegetables providing high quantities of alpha- and beta-carotene. It has been found that supplyiny a carotenoid content in the proportions noted above from vegetable sources of those carotenoids provides virtually the entire array of carotenoids in the appropriate distribution to duplicate the carotenoid ingestion from a balanced diet rich in vegetables.The carotenoids contained in vegetables not only include different carotenoids than those produced synthetically but additionally the carotenoids found in vegetables are superior to synthetic carotenoids because they differ in such things as structural distribution - for example, between cis- and trans- isomers.
Different vegetables contain different carotenoids, and even when they contain the same carotenoids they are in different proportions. For example, carrots are perhaps the best known source of beta-carotene but they contain no lycopene, while tomatoes are a rich source of lycopene but contain very little beta-carotene. Spinach is rich in lutein but has no lycopene and relatively little alpha-carotene. Each vegetable also contains an array of carotenoids that are lesser known, and no vegetable contains all of them.
All carotenoids are contained in the lipid portion of vegetables, so there is an option to use oleoresins extracted from vegetables or powdered, dried vegetables in the compositions of this invention. The decision to use powders or oleoresins is usually based on the cost or availability of oleoresins and the need to adjust the texture or viscosity of the composition. Most carotenoids survive carefully controlled processes such as spraydrying, freeze-drying, powdering, and extraction quite well. The composition of this invention, accordingly, provides a level of alpha-carotene, beta-carotene and lycopene that supplements the usual Western-culture diet to provide the proper intake of those three carotenoids.In addition, the composition of this invention, by being made from vegetable oleoresins and powdered vegetables, contains a whole array of natural carotenoids - those that have never been studied and those that are not non - and even the known carotenoids are provided in the proper structural distribution that one gets from a balanced diet of vegetables.
DETAILED DESCRIPTION OF THE I1TVENTIOT A composition embodying tis invention was made haviny the following ingredients on a weight basis.
Ingredient Percent Carrot oleoresin 26.1 Red bell pepper oleoresin 3.0 Peach powder 3.7 Strawberry powder 3.7 Tomato powder 44.9 Spinach powder 14.9 Apricot powder 3.7 The carrot and red pepper oleoresins were obtained by extraction from carrots and red bell pepper bodies respectively.
The carrot oleoresin was bright oranye, virtually flavorless and readily miscible in water. The red bell pepper oleoresin was a red liquid having the aroma of red bell peppers and very mild red bell pepper flavor.
The powdered material was all obtained by spray- or freeze-drying the noted ingredient and subdividing it to a powder form according to known techniques. The spinach was subjected to low-pressure steaming in a chamber for sufficient time to kill bacteria after which it was freeze-dried and powdered. Dried spinach and dried peach were powdered together to deal with the natural hygroscopicity of peach powder. The carotenoidcontaining materials were blended with vegetable oil and lecithin to provide an appropriate texture for encapsulating in a gelatin capsule. The materials were encapsulated in amounts providing 1.5 mg of beta-carotene, 0.5 mg of alpha-carotene and 0.4 mg of lycopene per capsule. The encapsulated materials also supplied other carotenoids that occur naturally in the powders and oleoresins stated in Table 1.
Eleven healthy men and women volunteers between 22 and 52 years of age participated in a study to test if the supplement raised blood carotenoid level. The volunteers had no history of chronic disease, they were taking no medications, they did not smoke, and they were all within 10 percent of ideal body weight for their heights. None of the volunteers had an unconventional dietary pattern, such as vegetarianism. Those volunteers who had been taking carotene-containing supplements stopped doing so two weeks before the study began. All of the volunteers were evaluated for such factors as weight, blood pressure, pulse and temperature at the beginning of the study, two weeks after the beginning of the study, and weekly thereafter.
The study lasted six weeks. During this entire time the diets of the volunteers were self-selected from lowcarotenoid foods on a list of foods provided to them. The volunteers were also given a list of carotenoid-containing foods that they were to avoid during the study. The recommended daily diets of the volunteers contained less than 0.4 mg of betacarotene and alpha-carotene and no lycopene. After two weeks cn the low-carotelloid diet the volunteers began taking sit of the capsules described above daily. This period was called the supplementation period and it continued for the next four weeks.
A fasting blood sample was collected from each volunteer before the beginning of the stud to establish a baseline serum carotenoid level for each subject that was characteristic of his or her own diet and physiologic absorption characteristics for carotenoids. The base-lines were for alphacarotene, beta-carotene and lycopene only. Blood samples were also collected after two weeks on the low carotenoid diet and weekly during the supplementation period. The samples were collected in accordance with recognized medical techniques, centrifuged to obtain plasma, and analyzed for alpha-carotene, beta-carotene and lycopene by the HPLC method of Bieri et al.
Table 2 below reports the data resulting from these tests. The columns headed A are the base-line readings of each volunteer at the start of the test. The columns headed B are the readings after two weeks on the low carotenoid diet at which time the supplementation period began. The columns headed C are the readings at the end of the study - that is, six weeks from the beginning of the study and four weeks from the beginning of the supplementation period. All reported values are in nanograms per milliliter of serum.
TABLE 2 Beta-Carotene Alpha-Carotene Lvcopene Volunteer A B C A B C A B C 1 1028 526 1065 422 241 541 728 433 302 2 530 371 1346 169 110 617 275 166 263 3 255 120 365 96 50 238 448 285 400 4 981 571 1170 177 125 428 254 151 238 5 73 21 72 80 20 56 180 126 125 6 156 111 377 44 33 240 437 213 172 7 341 290 1222 129 98 419 292 205 354 8 578 238 578 245 141 236 590 232 216 9 630 435 1254 302 154 495 453 316 343 10 302 169 907 110 79 510 780 284 225 11 154 107 204 43 45 145 856 692 724 From Table 2 it is evident that the data establish the general trend that two weeks on a low carotenoid diet significantly diminished the serum alpha- and beta-carotene levels of the volunteers.The data also establish that the composition of this invention taken in the four-week supplementation period restored the serum alpha- and betacarotene levels to the base-line level or in excess of the baseline level for each volunteer.
The data reporting lycopene levels were less conclusive. In yeneral there was a significant reduction in lycopene levels between the base-line levels and the start of the supplementation period but the supplementation period did not restore base-line levels. fIowever, plasma lycopene levels are known to respond slower to changes in dietary intake than alphaor beta-carotene levels. Lycopene supplementation initially stabilized lycopene plasma levels preventiny further decline. It is hypothesized that if the study had been prolonged, gradual increases in lycopene levels to or in excess of the base-line levels would be observed. The weekly tests for serum lycopene bear out this hypothesis. For all but two of the volunteers there was a rising trend in serum lycopene in the final week of the supplementation period.Specifically, the data for the final week were: Volunteer Fifth week Sixth week 1 312 302 2 220 263 3 174 400 4 168 238 5 20 125 6 135 172 7 101 354 8 77 216 9 281 343 10 274 225 11 705 724 As noted above, the volunteers were healthy persons before the test started. They were also healthy persons after the test ended. They noticed no subjective changes in their health during the six weeks of the test. It is known that serum carotenoid levels are accurate indicators of the availability of these essential compounds for maintaining yood health and that temporary periods of low serum carotenoid levels have no affect on the health of the average individual. However, chronic low carotenoid serum levels may cause health deterioration problems.
The study demonstrates that regular ingestion of the composition of this invention will maintain serum carotenoid levels even with a diet that is almost devoid of carotenoids. Its regular use will provide a person with significant ingestion of carotenoids regardless of the vegetable content of that person's usual diet.

Claims (8)

1. A composition comprising a suspension of powdered materials in an edible oil, said powdered materials comprising a mixture of dried, vegetables, said composition containing alphacarotene, beta-carotene and lycopene in proportion to one another on a weight basis of from about 20% to about 40% alpha-carotene, from about 55 to about 80t beta-carotene and from about 3% to about 20% lycopene.
2. The composition of claim 1 wherein said edible oil comprises carrot oleoresin.
3. The composition of claim 1 wherein said edible oil comprises red bell pepper oleoresin.
4. The composition of claim 1 wherein said powdered material comprises spinach powder.
5. The composition of claim 1 wherein said powdered material comprises tomato powder.
6. The composition of claim 1 enclosed in a gelatin capsule.
7. The composition of claim 6 wherein said capsule contains from about 500 to about 1000 milligrams of said composition.
8. A composition enclosed in a gelatin capsule comprising from about 150 to about 200 mg of carrot oleoresin, from about 30 to about 50 mg of red bell pepper oleoresin, from about 100 to about 400 mg of powdered, dried tomato, and from about 50 to about 200 mg of powdered, dried spinach.
GB9324188A 1993-01-13 1993-11-24 Carotenoid food supplement Expired - Lifetime GB2274235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US375793A 1993-01-13 1993-01-13

Publications (3)

Publication Number Publication Date
GB9324188D0 GB9324188D0 (en) 1994-01-12
GB2274235A true GB2274235A (en) 1994-07-20
GB2274235B GB2274235B (en) 1996-06-26

Family

ID=21707440

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9324188A Expired - Lifetime GB2274235B (en) 1993-01-13 1993-11-24 Carotenoid food supplement

Country Status (1)

Country Link
GB (1) GB2274235B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2301775A (en) * 1995-06-07 1996-12-18 Howard Foundation High dosage lutein and zeaxanthin for macula therapy
EP0759294A2 (en) * 1995-06-15 1997-02-26 Mutsunori Fujiwara Hypercholesterolemia therapeutic agent
EP0793491A1 (en) * 1994-12-22 1997-09-10 Henkel Corporation Pharmaceutical compositions comprising lycopene
WO1997047278A1 (en) * 1996-06-12 1997-12-18 Laboratoire Oenobiol Composition having tanning and sun-screening activity, and cosmetic uses thereof
FR2749757A1 (en) * 1996-06-12 1997-12-19 Oenobiol Sa Lab Composition having cosmetic tanning and sun-screen activity
US5858700A (en) * 1997-04-03 1999-01-12 Kemin Foods, Lc Process for the isolation and purification of lycopene crystals
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
US6329432B2 (en) 1993-06-28 2001-12-11 The Howard Foundation Mesozeaxanthin formulations for treatment of retinal disorders
US8163303B2 (en) * 1998-05-12 2012-04-24 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
CN102845538A (en) * 2012-07-03 2013-01-02 江南大学 Edible oil product rich in lycopene with cis-configuration and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2236655A (en) * 1989-09-18 1991-04-17 Yoshio Tanaka "Process for producing encapsulated foodstuff"
GB2265074A (en) * 1989-09-25 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff
GB2265072A (en) * 1990-01-30 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff
GB2265073A (en) * 1990-03-23 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2236655A (en) * 1989-09-18 1991-04-17 Yoshio Tanaka "Process for producing encapsulated foodstuff"
GB2265074A (en) * 1989-09-25 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff
GB2265072A (en) * 1990-01-30 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff
GB2265073A (en) * 1990-03-23 1993-09-22 Yoshio Tanaka Process for producing encapsulated foodstuff

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329432B2 (en) 1993-06-28 2001-12-11 The Howard Foundation Mesozeaxanthin formulations for treatment of retinal disorders
EP0793491A4 (en) * 1994-12-22 2000-01-12 Henkel Corp Pharmaceutical compositions comprising lycopene
EP0793491A1 (en) * 1994-12-22 1997-09-10 Henkel Corporation Pharmaceutical compositions comprising lycopene
US6362221B1 (en) 1994-12-22 2002-03-26 Cognis Corporation Compositions containing natural lycopene and natural tocopherol
GB2301775A (en) * 1995-06-07 1996-12-18 Howard Foundation High dosage lutein and zeaxanthin for macula therapy
GB2301775B (en) * 1995-06-07 1999-08-04 Howard Foundation Treatment of age-related macular degeneration with carotenoids
EP0759294A2 (en) * 1995-06-15 1997-02-26 Mutsunori Fujiwara Hypercholesterolemia therapeutic agent
EP0759294A3 (en) * 1995-06-15 1999-12-01 Mutsunori Fujiwara Hypercholesterolemia therapeutic agent
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
WO1997047278A1 (en) * 1996-06-12 1997-12-18 Laboratoire Oenobiol Composition having tanning and sun-screening activity, and cosmetic uses thereof
FR2749758A1 (en) * 1996-06-12 1997-12-19 Oenobiol Sa Lab COMPOSITION WITH BRONZING AND PHOTOPROTECTIVE ACTIVITY AND ITS AESTHETIC APPLICATIONS
FR2749757A1 (en) * 1996-06-12 1997-12-19 Oenobiol Sa Lab Composition having cosmetic tanning and sun-screen activity
US5858700A (en) * 1997-04-03 1999-01-12 Kemin Foods, Lc Process for the isolation and purification of lycopene crystals
US8163303B2 (en) * 1998-05-12 2012-04-24 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
CN102845538A (en) * 2012-07-03 2013-01-02 江南大学 Edible oil product rich in lycopene with cis-configuration and preparation method thereof

Also Published As

Publication number Publication date
GB2274235B (en) 1996-06-26
GB9324188D0 (en) 1994-01-12

Similar Documents

Publication Publication Date Title
Leitzmann Characteristics and health benefits of phytochemicals
Khachik et al. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer
Vuong et al. Plasma β-carotene and retinol concentrations of children increase after a 30-d supplementation with the fruit Momordica cochinchinensis (gac)
Ko et al. Comparison of the antioxidant activities of nine different fruits in human plasma
Goluch-Koniuszy Nutrition of women with hair loss problem during the period of menopause
US5904924A (en) Green nutritional powder composition
Botsoglou et al. Effect of dietary oregano essential oil on performance of chickens and on iron-induced lipid oxidation of breast, thigh and abdominal fat tissues
EP1716210B1 (en) Compositions containing cis-isomers of carotenoids and corresponding method
US5976548A (en) Nutritional supplement composition and use
Cao et al. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables
van het Hof et al. Bioavailability of lutein from vegetables is 5 times higher than that of β-carotene
Müller et al. Plasma concentrations of carotenoids in healthy volunteers after intervention with carotenoid-rich foods
Barua et al. Xanthophyll epoxides, unlike β-carotene monoepoxides, are not detectibly absorbed by humans
Baron et al. Functional properties of Omani dates (Phoenix dactylifera L.)
Gitenay et al. Comparison of lycopene and tomato effects on biomarkers of oxidative stress in vitamin E deficient rats
GB2274235A (en) Carotenoid food supplement
CN101522057A (en) Stable and bioavailable compositions of isomers of carotenoids for skin and hair
WO1998000024A1 (en) Nutritional supplement composition and use
WO1999048487A1 (en) Multi-carotenoid product
Ahmad et al. Role of by-products of fruits and vegetables in functional foods
DE10219139A1 (en) Supplements for dietetic foods or for treating various illnesses, contain phytamines embedded in the cell structure of plant homogenizates
KR20050099310A (en) Health functional food with white-green fruits and vegetables and manufacturing method thereof
Turturică et al. Carrot–Application in food industry and health benefits–review
Challem Beta-carotene and other carotenoids: promises, failures, and a new vision
Mahmoud et al. Evaluation of a new baby food prepared from Opuntiaficusindica fruit in Wistar rats with either calcium deficient or vitamin A depletion

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Expiry date: 20131123